Celldex Therapeutics Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include Celling Biosciences and UCB.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Celling Biosciences Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2018 | Founding Date 2013 | Founding Date 1928 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Houston, US HQ | Locations Austin, US HQ Curitiba, BR Dubai, AE | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 888% decrease | Employees 47 | Employees 9,052 |
Valuation ($) | Valuation ($) 36.5 m | Valuation ($) N/A | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) |
Net income | Net income ($12.2m) (FY, 2025) | Net income N/A | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Celling Biosciences
HQ
Austin, US
Employees
47
Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company